生物电阻抗分析测定液体状态在失代偿性心力衰竭诊治和预后评估中的作用  

Bioimpedance analysis in acute decompensated heart failure

作　　者：张如意 王宏[1] 秦晨 张金 生乙辰 孙健[1] ZHANG Ruyi;WANG Hong;QIN Chen;ZHANG Jin;SHENG Yichen;SUN Jian(Department of Cardiology,the First Bethune Hospital of Jilin University,Changchun,130000,China;Department of Neurology,the First Bethune Hospital of Jilin University,Changchun,130000,China)

机构地区：[1]吉林大学第一医院心血管中心内科组,长春130000 [2]吉林大学第一医院神经内科,长春130000

出　　处：《临床心血管病杂志》2020年第7期672-677,共6页Journal of Clinical Cardiology

摘　　要：急性失代偿性心力衰竭(ADHF)的诊断及支持治疗需要根据其特定的发病机制制定即时的治疗策略。生物电阻抗分析(BIA)评估液体状态对呼吸困难患者急性心力衰竭(心衰)具有诊断意义。心衰患者发生体液潴留,而BIA可以用于评估患者细胞外及身体总水分,对于急性心衰、急性肾衰、慢性肾衰透析、营养不良等患者具有辅助诊断及辅助调整治疗的作用。本文分析应用BIA测定的患者液体状态与心衰诊断、病情评估、治疗及预后判断之间的关系。Bioimpedance analysis(BIA)can be used to evaluate fluid status for acute decompensated heart failure(ADHF)in patients with dyspnea.BIA was used for hospitalized patients routinely diagnosis method,treatment strategy determination,assessment of prognosis,therapeutic effect evaluation and evaluation means of daily out-hospital care.The purpose of this study was to analyze the relationship between BIA,and the diagnosis,assessment,treatment decision,prognosis of patients with ADHF.

关 键 词：急性失代偿性心力衰竭 生物电阻抗分析 液体管理 

分 类 号：R541.6[医药卫生—心血管疾病]